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Doxycycline resistance in Plasmodium falciparum linked to single nucleotide polymorphisms in 
the Plasmodium falciparum apicoplast small subunit ribosomal RNA (pfSSrRNA) gene 
 
Plasmodium falciparum, a protozoan parasite known as malaria, widely impacts human 
health; thus antimalarial drug investigations are critical. Doxycycline is a commonly used 
antimalarial prophylactic, but its mechanism of action is unclear. In prokaryotes, doxycycline 
works as an antibacterial by disrupting protein translation via the small subunit ribosome. 
Interestingly, P. falciparum has a small subunit ribosome of prokaryotic origins in the apicoplast, 
a plastid-like organelle. Therefore, we hypothesized that doxycycline works in P. falciparum by 
inhibiting protein synthesis via the small subunit ribosomal RNA and that mutations in the gene 
encoding the P. falciparum apicoplast small subunit ribosomal RNA (pfSSrRNA) are associated 
with doxycycline resistance. We generated nine doxycycline-resistant parasite lines with 
continuous incremental drug pressure over approximately twelve months. Resistant lines had 
doxycycline IC50 values of ~2.4 μM while the drug-free control had an IC50 of 587 nM, resulting 
in a ~4 fold decrease in doxycycline susceptibility as measured by 96-hour growth inhibition 
assays. Sequencing of the pfssrRNA gene in a resistant line revealed a g439a single nucleotide 
polymorphism (SNP). We suspect this mutation reduces parasite susceptibility to doxycycline by 
altering the molecular structure of the apicoplast SSrRNA, so that doxycycline can no longer 
inhibit protein synthesis. Future studies involve cloning the resistant lines, sequencing pfssrRNA 
for all resistant lines, and characterizing the drug phenotypes of the resistant lines to doxycycline 
and a panel of standard antimalarial drugs. Understanding how doxycycline works will help 
health care professionals better combat doxycycline resistance in the field.  
 
